4.4 Article

The immunogenicity of biosimilar infliximab: can we extrapolate the data across indications?

Journal

Expert Review of Gastroenterology & Hepatology
Volume 9, Issue sup1, Pages 27-34

Publisher

Informa UK Limited
DOI: 10.1586/17474124.2015.1091307

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available